D endritic cells (DC)
3 are a trace population of bone marrow-derived APCs, irregular in shape and widely distributed in both lymphoid and nonlymphoid tissues (1, 2) . Those having migrated to nonlymphoid tissues such as the epidermal layer of the skin, the respiratory and gastrointestinal systems, and interstitial regions of solid organs are considered immature. On the contrary, fully mature DC are located in lymphoid organs. After Ag internalization and inflammation, DC leave the tissues interfacing with the external environment and enter the lymphatic vessels to reach the lymphoid organs and undergo maturation (1) (2) (3) . Although still immature, the primary function of DC is to capture and process Ags, then to present the antigenic peptides and activate specific T cells (1, 2) . In fact, DC have adhesion molecules to ensure T cell contact, high surface levels of MHC II molecules for peptide presentation, and costimulatory molecules such as CD80-B7-1 and CD86-B7-2. T cells may in turn induce DC maturation via CD40 binding (1, 2) . The ability of DC to migrate from areas of Ag encounter to sites of T cell priming is fundamental to their capacity of stimulating an immune response; however, how DC know where to go is still rather obscure. The major route of DC entry into lymph nodes are the afferent lymphatic vessels (3, 4) . Chemokines expressed by endothelial cells in lymphatics and lymph node venules and chemokine receptors in DC seem to contribute to DC migration as chemoattractants and by triggering integrin-dependent adhesive interactions (4 -6) . However, the primary force that drives DC displacement is the lymphatic circulation. Lymph flow is regulated by spontaneous contraction of lymphatic vessel smooth muscle that in turn is stimulated by sympathetic nerves and adrenergic receptors (ARs) (7) . The AR mediate the functional effects of epinephrine and norepinephrine (NE) by coupling to several of the major signaling pathways modulated by G proteins. The AR family includes nine different gene products: three ␤ (␤ 1 , ␤ 2 , ␤ 3 ), three ␣ 2 (␣ 2A , ␣ 2B , ␣ 2C ), and three ␣ 1 (␣ 1a , ␣ 1b , ␣ 1d ) receptor subtypes. The ␣ 1 -ARs are present in several tissues, including brain, heart, blood vessels, liver, kidney, prostate, and spleen, where they mediate a variety of physiological effects such as cardiac inotropy and chronotropy, vasocontraction, glycogenolysis, and the contractions of the urinary tract (8) . On the other hand, the interaction between sympathetic nerves and cells of the immune system has been demonstrated in terms of distribution of tyrosine hydroxylase-positive fibers in lymphoid organs, expression of ARs on cells of the immune system, and immunomodulatory effects of the main sympathetic neurotransmitter NE (9 -11). We reported that catecholamines can also exert important hemopoietic effects via ␣ 1 -ARs expressed in bone marrow progenitor cells (12) (13) (14) (15) (16) . Relevant to the present study, NE has been shown to stimulate lymphoid cell mobilization via ␤-ARs (17).
Materials and Methods

Mice
Female 2-to 3-mo-old C57BL/6 or C3H/He inbred mice were purchased from Charles River Breeding Laboratories (Calco, Italy) and maintained in our animal room under a standard 12-h photoperiod, at 21 Ϯ 1°C, with food and water ad libitum for at least 10 days before the experiments. penicillin, 100 g/ml streptomycin, and 20 ng/ml GM-CSF (PeproTech, Rocky Hill, NJ); and incubated in 100-mm-diameter bacteriological petri dishes. At day 3, 10 ml of complete culture medium was added to the plates. At days 6 and 8, half of the culture supernatant was collected and centrifuged, and the cell pellet was resuspended in 10 ml of complete culture medium and given back to the original plate. At day 10, cells were collected, layered onto a metrizamide gradient (14.5 g in 100 ml of RPMI 1640 culture medium), and centrifuged for 10 min at 600 ϫ g. Then the low-density cell fraction was depleted from lymphocytes and GR-1 ϩ cells using a mixture of mAbs and rabbit complement for 60 min at 37°C. The mAbs used were anti-CD4, TIB 207 GK1.5; anti-CD8, TIB 2109 2.43; and anti-B220, TIB 146 RAB-BA1/61 (American Type Culture Collection, Manassas, VA). GR-1 mAb was purchased from PharMingen (Basel, Switzerland). After depletion, cells were washed and analyzed by flow cytometry. Cells showing a typical dendritic morphology were always Ͼ90%, whereas the DC marker CD11c was invariably found on Ͼ95% of the cells. High expression of major histocompatibility class II Ags and of the costimulatory molecule CD86 (B7-2), typical of mature DC, was expressed by 25-30% of the cells. In general, cell yield and degree of maturation agreed with the reported method (18) . 
In vivo migration of epidermal Langerhans cells
Mice were painted on the shaved back with 50 l of 1% FITC (Sigma, St. Louis, MO) dissolved in a 50:50 (v/v) acetone-dibutylphtalate mixture. Twenty-four hours after painting with FITC in the presence or absence of 10 M prazosin (PRA; Sigma) or 10 M propranolol (Sigma), the mice were killed and single-cell suspensions were prepared from inguinal, axillary, and brachial lymph nodes. Other groups of mice were injected i.p. with yohimbine (5 mg/kg body weight; Sigma) or phosphate saline just after FITC painting. Lymph nodes were incubated in collagenase A (0.5 mg/ml; Boehringer Mannheim, Rot Kreuz, Switzerland) and DNase I (40 g/ml; Perkin-Elmer, Rot Kreuz, Switzerland)) for 10 min at 37°C. Afterward, the tissue was teased and cells were filtered through a 70-m cell strainer (Falcon; Becton Dickinson). Cells were washed and layered onto a metrizamide gradient (14.5 g in 100 ml RPMI 1640 culture medium) and centrifuged for 10 min at 600 ϫ g. Cells at the interface were collected, washed, and labeled with PE-conjugated anti-CD86 (PharMingen) mAb and analyzed by flow cytometry. Cells labeled with both FITC and PE were quantitated as migrated Langerhans cells.
Skin organ culture
Ears from mice were rinsed with 70% ethanol and air dried for 10 min. Ear skin was split in dorsa and ventral halves, and the dorsal halves were cultured in a 24-well tissue culture plate in 2 ml of RPMI 1640, 10% FCS, 2 mM glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin. Adrenergic agents were added at the beginning of the culture. After 24 h, the ear halves were removed and free cells were collected, centrifuged, and counted in trypan blue. DC were identified morphologically as large veiled cells.
Assay for contact hypersensitivity (CHS) to FITC
Mice were sensitized by painting 400 ml of 0.5% FITC with or without the adrenergic antagonists (PRA, 10 M; propranolol, 10 M) on the shaved trunk, and 6 days later were challenged by applying 20 l of 0.5% FITC on the dorsal and ventral sides of the right ear. As a control, the left ear was painted with an identical amount of vehicle (acetone-dibutylphtalate, 1:1). The CHS response was determined by measuring the degree of ear swelling of the FITC-painted ear compared with that of the vehicle-treated contralateral ear at 24 h after challenge using a digital micrometer (Mitutoyo, Kawasaki, Japan). The results were expressed as net ear swelling, which was calculated by subtracting the thickness of the vehicle-treated ear from the thickness of the FITC-challenged ear.
In vitro migration
Cell migration was evaluated in vitro using a chemotaxis chamber technique. A total of 27 l of a chemoattractant solution containing NE (Sigma), isoproterenol (Sigma), the chemokines 6Ckine and RANTES (R&D Systems, Abingdon, U.K.), or control medium RPMI 1640 and 1% FCS were added to the lower wells of a chemotactic chamber (Neuroprobe, Gaithersburg, MD). A polycarbonate filter (5-m pore size; Neuroprobe) was layered onto the wells and covered with a silicon gasket and a top plate. A total of 50 l of cell suspension (1.5 ϫ 10 6 cells/ml) was seeded in the upper chamber. In certain experiments, NE or PRA was added in the upper wells along with DC. The chamber was incubated at 37°C for 90 min. At the end of the incubation, filters were removed and stained with Diff-Quick (Dade Behring, Düdingen, Switzerland), and high-power fields (ϫ100) were counted. Results are expressed as the mean number of migrated cells in 10 fields.
CD40-induced maturation
For CD40 cross-linking, DC were incubated in ice for 10 min in phosphate saline plus 10% mouse serum for 20 min with hamster anti-mouse CD40 mAb (5 g/ml; PharMingen) and then overnight at 37°C with goat antihamster Abs (Pierce, Rockford, IL) in IMEM plus 10% FCS. Morphometric and flow cytometry analysis showed that Ͼ95% of CD40-stimulated cells were mature DC.
RT-PCR
Total RNA isolated from 5 ϫ 10 6 cells was reverse transcribed using 400 U of SuperScript RT (Life Technologies, Basel, Switzerland) and 40 U of RNase inhibitor (Perkin-Elmer, Rot Kreuz, Switzerland) in 50 mM TrisHCl (pH 8.3), 75 mM KCl, 3 mM MgCl 2 , 10 M dithyotretol, 60 M random hexamers, 4.3 M polyT (16 -18) , and 500 M of each deoxynucleotide were added, and the mix was incubated for 1 h at 37°C. cDNA amplification was performed in 50 mM KCl, 10 mM Tris (pH 8.6), 1.5 mM MgCl 2 , 250 M deoxynucleotides, 0.5 M primers (Genset, Paris, France), and 2.5 U of AmpliTaq polymerase (Perkin-Elmer). Forty cycles of PCR were performed according to the following steps: 94°C, 4 min (once); 94°C, 2 min; 46°C, 1 min; and 72°C, 2 min. At the end, the reaction mixture was kept for 10 min at 72°C and finally chilled in ice until analysis. For selection of the primers, we referred to the National Center for Biotechnology Information database. The primers sequence is reported, as follows: ␣ 1a , upstream, 5Ј-CCTGGTTATGTACTGTCGAGTCTAC-3Ј, and downstream, 5Ј-TATGATAGGGTTGATGCAACTATTT-3Ј; ␣ 1b , upstream, 5Ј-CCAACCAACTACTTCATTGTCA-3Ј, and downstream, 5Ј-GCCAACA TAAGATGAACATTCC-3Ј; and ␣ 1d , upstream, 5Ј-CTTCTCTTCCGTAT GCTCCTTCTA-3Ј, and downstream, 5Ј-GGGTTCACACAGCTATTGA AGTAG-3Ј.
The RNA quality was controlled by amplifying hypoxanthine-guanine phosphoribosyltransferase mRNA using the following oligonucleotides as primers: upstream, 5Ј-GATTATGGACAGGACTGAAAG-3Ј and downstream, 5Ј-CGAGAGGTCCTTTTCACCAGC-3Ј.
In vivo migration of passively transferred DC
I-A b DC were incubated with chloroethylclonidine (10 M; Sigma) for 30 min at 37°C or with culture medium alone. After washing, 5 ϫ 10 5 cells in 50 l were then injected s.c. into the hind footpads of I-A k mice. Fortyeight hours after injection, the mice were killed, and the popliteal and inguinal lymph nodes were removed. Single-cell suspensions of lymph node cells were centrifuged on a metrizamide gradient, and the low-density DC fraction was harvested. Flow cytometry analysis was performed to detect I-A b -positive cells.
Results
Langerhans cells migration
We studied whether NE participates in determining the emigration pathway of skin DC such as epidermal Langerhans cells. We used the fluorescent molecule FITC as an Ag to induce migration of Langerhans cells to regional lymph nodes. Mice were painted with FITC on the back after shaving, and the effect of adrenergic agents was evaluated in terms of the number of cells positive for both FITC and CD86 (B7-2) found 24 h later in the draining lymph nodes. The results obtained show that topical application of the ␣ 1 -adrenergic antagonist PRA, but not the ␤-adrenergic antagonist propranolol inhibited migration of Langerhans cells to the draining lymph nodes (Fig. 1 ). In addition, the i.p. injection of yohimbine, an ␣ 2 -adrenergic antagonist that increases the noradrenergic tone, resulted in a significant increase of migrated Langerhans cells.
Altogether these results suggest that NE is involved in skin DC migration via ␣ 1 -ARs. 
Emigration of skin DC in organ cultures
A strong stimulation of DC emigration from dorsal halves of ear skin was noted when NE was added in the culture medium. On average, a 3-fold increase of migrated DC was found in the presence of NE, and a 4-fold increase was found using the chemokine 6Ckine as positive control (Table I) . As expected, the ␣ 1 -AR antagonist PRA inhibited the NE effect (Table I) . These results confirmed that NE can mobilize skin DC via ␣ 1 -ARs.
CHS response to FITC
To investigate whether the adrenergic inhibition of skin DC migration in vivo results in an altered development of DC-dependent immune response, we measured the CHS response to FITC after sensitization in presence of either PRA or propranolol. Fig. 2 shows that PRA, but not propranolol treatment during sensitization inhibited the CHS response expressed as net ear swelling after FITC challenge 6 days later. This indicated that the PRA-induced inhibition of DC migration resulted in a reduced sensitization to FITC.
In vitro DC migration
To study in greater detail the possibility that NE is involved in DC migration, we set up experiments in a chemotaxis microchamber using NE or the synthetic ␤-adrenergic agonist isoproterenol as chemoattractants. Fig. 3 shows that NE, but not isoproterenol, is indeed a powerful chemoattractant for bone marrow-derived DC. The DC generated from bone marrow cultures were heterogeneous for their expression of MHC class II and B7-2, i.e., for their degree of maturation. With this cell population containing immature DC, NE 10 Ϫ6 M (319.3 ng/ml) exerted a chemotactic activity that was intermediate in comparison with those exerted by RANTES (100 ng/ml) and the secondary lymphoid tissue chemokine 6Ckine (120 ng/ml), which has been recently suggested to play a role in migration and homing of mature DC (19 3) .
Checkerboard analysis revealed that not only is NE a chemoattractant for DC, but it may also induce chemokinesis (Fig. 4) . When seeded in the upper chamber together with the cells, NE prevented spontaneous (control) migration, but not the chemotactic activity of RANTES (Fig. 4) . However, although less than toward a NE gradient (NE in lower wells only), DC also migrated in a constant NE concentration (10 Ϫ6 M NE both in the upper and a The values represent the mean number of cells emigrated from one ear skin dorsal halve Ϯ SD during a 24-h incubation and the percentage of migration taking the control group as 100%. 6Ckine was used as positive control.
b p Ͻ 0.001 vs medium, NE ϩ PRA, PRA (ANOVA). lower wells; Fig. 4 ). These results indicate that NE is both a chemoattractant and a chemokinetic factor for immature, but not for mature DC.
Expression of ␣ 1 -ARs in DC
The PRA sensitivity of DC migration and the lack of effect of ␤-adrenergic agents both in vivo and in vitro imply the participation of ␣ 1 -ARs. This type of AR has been indeed reported to mediate the effect of catecholamines on lymphatic vessels (20) . However, our studies suggest that DC may likewise express ␣ 1 -ARs.
To elucidate this point, we investigated the presence of mRNA coding for the three ␣ 1 -AR subtypes (a, b, and d) in bone marrowderived DC before and after CD40 stimulation. RT-PCR analysis revealed the expression of the ␣ 1b -AR mRNA in bone marrowderived DC. Apparently, the other two ␣ 1 -AR subtypes were not expressed (Fig. 5) . The ␣ 1b -AR mRNA expression was, however, almost undetectable in DC stimulated by anti-CD40 Abs (Fig. 5) . This is most likely the reason that NE does not attract mature CD40-stimulated DC (Fig. 3) . Presumably, the ␣ 1b -AR is expressed in an immature fraction of bone marrow-derived DC. This would agree also with the in vivo effect of PRA on epidermal Langerhans cells (Fig. 1 ) that are considered immature DC (21) .
Migration of adoptively transferred DC
To further investigate the role of DC ␣ 1b -AR in vivo, we performed experiments in which bone marrow-derived I-A b -positive (C57BL/6) DC were preincubated with the irreversible and selective ␣ 1b -AR antagonist chloroethylclonidine and then injected into the hind footpads of I-A k (C3H/He) mice. Forty-eight hours after injection, the number of I-A b -positive DC that migrated to the popliteal and inguinal lymph nodes were evaluated by flow cytometry. Table II shows that incubation of bone marrow-derived DC with chloroethylclonidine impairs their migration from the footpad to regional lymph nodes.
Discussion
Altogether, these findings suggest that ␣ 1b -ARs expressed in DC drive at least part of their emigration pathway to regional lymph nodes. In vivo, the effect of PRA and yohimbine suggests that endogenous NE indeed plays a role in DC migration. PRA and propranolol were administered topically to possibly target Langerhans cells or other epidermal structures, whereas yohimbine was injected i.p. because its well-known sympathomimetic activity depends on blockade of both peripheral and central presynaptic ␣ 2 -ARs. In addition, NE greatly stimulated skin DC emigration in organ cultures, and the NE effect was neutralized by PRA. This indicates that the effect of PRA and yohimbine in vivo (Fig. 1) was not dependent on an altered FITC labeling of DC. Finally, preincubation of DC with the irreversible ␣ 1b -AR antagonist chloroethylclonidine resulted in impaired migration when DC were adoptively transferred. It should be noted that after the chloroethylclonidine exposure, DC were viable and retained the ability to migrate in vitro against RANTES, but not against NE (data not shown). Therefore, the impaired migration of these DC in vivo was probably due to the irreversible inactivation of the ␣ 1b -AR, and this confirmed a role for NE in DC migration in vivo. Most interesting, the inhibition of DC migration induced by PRA was followed by an impaired DC-dependent immune response, as shown in the CHS experiments (Fig. 2) . Probably the impaired DC migration resulted in a reduced Ag presentation and T cell activation.
In vitro, NE exerted a powerful chemoattractant/chemokinetic effect on bone marrow-derived immature DC via their ␣ 1b -AR. The fact that CD40-stimulated mature DC show a very low expression of the ␣ 1b -AR may explain why NE did not act on these cells and suggests that, unlike 6Ckine (5), NE is not involved in the homing of mature DC in lymph nodes. 6Ckine is, in fact, strongly expressed in the high endothelial venules of lymph nodes and has been shown to mediate both chemotaxis and adhesion of mature, but not immature DC (5) .
Possibly, the rich sympathetic innervation of lymphatic smooth muscle (7) creates a NE gradient able to recruit immature DC from nonlymphoid tissues. Nerve fibers are in fact present in the tunica externa and media of afferent lymphatic vessels. Thus, the sympathetic innervation of lymphatic vessels would have the dual role of stimulating smooth muscle contraction, which in turn promotes lymph flow, and of recruiting DC. Nevertheless, an alternative physiological interpretation of the results obtained may also be proposed. Since NE appears to be also chemokinetic (Fig. 4) and DC seem to lose their sensitivity to NE during maturation, it might be that under condition of enhanced sympathetic activity (stress, anxiety, cold exposure), increased DC chemokinesis enhances the ability of DC to sample local Ags. This would result in an increased number of maturing DC that can be attracted by relevant chemokines such as 6Ckine and reach the draining lymph nodes. In any case, NE might interact with the chemoattractant activity of chemokines that are expressed at sites of inflammation to activate Ag uptake (22) . This, however, does not seem to apply for RAN-TES (Fig. 3) . A better understanding of the role of NE in DC migration requires more detailed studies on the interaction between the ␣1b-AR, antigenic activation, and locally produced inflammatory cytokines and chemokines (4).
In conclusion, we show that immature DC express ␣ 1b -ARs that participate in cell mobilization and migration to regional lymph nodes. This finding should be considered in studies concerning skin diseases, allergy, and autoimmune disorders. As far as it concerns skin diseases, psoriasis and atopic dermatitis may worsen with anxiety (23), a behavioral condition that can be mimicked pharmacologically by yohimbine, which is known to augment catecholamine release. The fact that yohimbine accelerates skin DC migration might be relevant in our understanding of these elusive yet widespread skin diseases. In addition, our finding might open new pharmacological possibilities for modulating the immune response.
